CAS: 2162134-62-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Garadacimab REF: TM-T77018CAS: 2162134-62-3 | SDS-PAGE:95% SEC-HPLC:99.99% | 291.00 €~2,471.00 € | Tue 16 Jul 24 |
 | Garadacimab REF: 3D-CLA1563CAS: 2162134-62-3 | - - - | To inquire | Fri 26 Jul 24 |
Garadacimab
CAS:2162134-62-3
Garadacimab (CSL312) is a human IgG4 antibody against FXIIa, used to research hereditary angioedema.
Purity:
SDS-PAGE:95% SEC-HPLC:99.99%
Color and Shape:
Solid
Ref: TM-T77018
| 1mg | 291.00 € | ||
| 5mg | 601.00 € | ||
| 10mg | 916.00 € | ||
| 25mg | 1,356.00 € | ||
| 50mg | 1,830.00 € | ||
| 100mg | 2,471.00 € |
Estimated delivery in United States, on Tuesday 16 Jul 2024
Garadacimab
CAS:2162134-62-3
Humanized IgG4 monoclonal antibody targeting activated factor XII (FXIIa).
Ref: 3D-CLA1563
| Undefined size | To inquire |
Estimated delivery in United States, on Friday 26 Jul 2024
